METASTATIC MELANOMA
Clinical trials for METASTATIC MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a drug tame Immunotherapy's worst side effects in melanoma?
Disease control Not yet recruitingThis early study tests whether giving an IL-17 blocker (secukinumab) to people with advanced melanoma can lower the risk of severe immune-related side effects when they restart immunotherapy. Only 4 participants who previously had side effects like colitis or skin rash from check…
Matched conditions: METASTATIC MELANOMA
Phase: PHASE1 • Sponsor: Duke University • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New immunotherapy combo targets advanced melanoma in india
Disease control Not yet recruitingThis study tests a combination of two immunotherapy drugs (nivolumab and relatlimab) in 30 people in India with advanced melanoma that has not been treated before. The main goal is to check safety and side effects, and also to see how well the drugs shrink tumors. Participants mu…
Matched conditions: METASTATIC MELANOMA
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 22, 2026 14:03 UTC